Lavaca Capital LLC Viatris Inc Transaction History
Lavaca Capital LLC
- $283 Million
- Q3 2025
A detailed history of Lavaca Capital LLC transactions in Viatris Inc stock. As of the latest transaction made, Lavaca Capital LLC holds 37 shares of VTRS stock, worth $396. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37
Previous 137
72.99%
Holding current value
$396
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding VTRS
# of Institutions
1,132Shares Held
966MCall Options Held
7.74MPut Options Held
2.47M-
Vanguard Group Inc Valley Forge, PA140MShares$1.5 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$993 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD84.1MShares$901 Million0.09% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az69.3MShares$743 Million3.68% of portfolio
-
State Street Corp Boston, MA55.7MShares$597 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...